Inflammation, glucocorticoids and risk of cardiovascular disease

Nature Clinical Practice Rheumatology

Volumn 5, Issue 1, 2009, Pages 18-19

  Buttgereit, Frank ^a   Burmester, Gerd Rüdiger ^a   Lipworth, Brian J ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; VITAMIN D;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE METABOLISM; BONE TURNOVER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; HAPLOTYPE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; INFLAMMATORY DISEASE; ISCHEMIC HEART DISEASE; LONG TERM CARE; LOW DRUG DOSE; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; RISK ASSESSMENT; RISK FACTORS;

EID: 58049202756     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0963     Document Type: Article

References (10)

1. van den Akker EL et al. (2008) Glucocorticoid receptor gene and risk of cardiovascular disease. Arch Intern Med 168: 33-39
2. Raterman HG et al. (2008) Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk. Ann Rheum Dis 67: 229-232
3. Karp I et al. (2008) Recent corticosteroid use and recent disease activity: Independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum 59: 169-175
4. Kaplan MJ (2006) Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 18: 289-297
5. Karp I et al. (2004) Updated risk factor values and the ability of the multivariable risk score to predict coronary heart disease. Am J Epidemiol 160: 707-716
6. Buttgereit F et al. (2004) Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action. Arthritis Rheum 50: 3408-3417
7. Souverein PC et al. (2004) Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case - control study. Heart 90: 859-865
8. Haugeberg G et al. (2005) Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: Results from a randomized placebo-controlled trial. Arch Intern Med 165: 1293-1297
9. Kirwan J et al. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD006356. doi:10.1002/ 14651858.CD006356
10. da Silva JAP et al. (2006) Safety of low dose glucocorticoid treatment in rheumatoid arthritis: Published evidence and prospective trial data. Ann Rheum Dis 65: 285-293